David J. Cantor
Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104
West Pavilion, 2nd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status-A Real-World Analysis in Patients With Advanced NSCLC.
Journal: Clinical lung cancer
Published: December 09, 2024
Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC.
Journal: JTO clinical and research reports
Published: October 03, 2023
Targeting KRAS-Mutated NSCLC: Novel TKIs and Beyond.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 20, 2023
Impaired Expression of Rearranged Immunoglobulin Genes and Premature p53 Activation Block B Cell Development in BMI1 Null Mice.
Journal: Cell reports
Published: September 07, 2018
The potential of targeting Sin3B and its associated complexes for cancer therapy.
Journal: Expert opinion on therapeutic targets
Published: September 29, 2017
Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
Journal: Cancer research
Published: December 14, 2016
The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in mice.
Journal: Blood
Published: June 10, 2016
SIN3B, the SASP, and pancreatic cancer.
Journal: Molecular & cellular oncology
Published: August 22, 2014
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Journal: The Journal of clinical investigation
Published: December 09, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026